Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Various gastrointestinal microorganisms, toxins, and allergens represent a broad category of luminal agents that can induce gastrointestinal pathology. This group includes pathogenic bacteria such as Vibrio cholerae, viruses like Norovirus, bacterial enterotoxins, and dietary proteins that trigger hypersensitivity (Guerrant et al., 2001, Clinical Infectious Diseases). These agents typically cause disease by disrupting the intestinal epithelial barrier, stimulating excessive fluid secretion, or activating the mucosal immune system (Sicherer & Sampson, 2018, Journal of Allergy and Clinical Immunology). Pharmacological management often utilizes non-absorbable binders or adsorbents, such as diosmectite or activated charcoal, which physically trap these substances within the gut lumen (Dupont et al., 2009, Alimentary Pharmacology & Therapeutics). By preventing the interaction of these agents with the host's intestinal lining, these treatments help mitigate symptoms like diarrhea and inflammation while facilitating the elimination of the offending agents from the body (Juurlink, 2016, British Journal of Clinical Pharmacology). This category is primarily used in the context of non-systemic gastrointestinal therapies that act through physical rather than biochemical mechanisms.
Physical adsorption and sequestration of luminal contents to prevent mucosal interaction and systemic absorption.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Various gastrointestinal microorganisms, toxins, and allergens.